Study Says Meridia May Up Risk Of Heart Attack, Stroke

Law360, New York (September 2, 2010, 11:15 AM EDT) -- A study published Thursday in The New England Journal of Medicine warned that Abbott Laboratories’ weight-loss drug Meridia may increase the risk of nonfatal heart attack and stroke in some users, raising new concerns about the controversial pill just weeks before a U.S. advisory panel is set to consider its fate.

The Abbott-funded study found that Meridia — the brand name for sibutramine hydrochloride — could increase the chances of nonfatal heart attacks and strokes in obese users over the age of 55 years with preexisting...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.